--2024/Q3-- / 13.463M--
--2024/Q2-- / 13.047M--
--2024/Q17.410M / 14.664M--
--2023/Q4316.192M / 33.673M--
--2023/Q317.193M / 23.893M--
US Stock MarketDetailed Quotes
BEAM Beam Therapeutics
- 33.140
- +0.970+3.02%
Close Jul 26 16:00 ET
- 33.140
- 0.0000.00%
Post 20:02 ET
2.73BMarket Cap-20712P/E (TTM)
34.090High32.350Low1.09MVolume32.720Open32.170Pre Close36.24MTurnover1.42%Turnover RatioLossP/E (Static)82.31MShares49.50052wk High2.99P/B2.54BFloat Cap16.95052wk Low--Dividend TTM76.56MShs Float138.522Historical High--Div YieldTTM5.41%Amplitude13.000Historical Low33.239Avg Price1Lot Size
Beam Therapeutics Key Stats
Beam Therapeutics Earnings Date
Currency: USD
Period
Q1 FY2024 Earnings
--
Revenue(YoY)
7.41M
-69.39%EPS(YoY)
-1.21
+9.02%Analyst Rating
Jul 26, 2024
Beam Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 12 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Beam Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
